Chemotherapy before surgery for stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two chemotherapy combinations given before surgery for stomach cancer that has not spread. The goal is to see which treatment works better and to shrink the tumor before removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach cancer or cancer where the stomach meets the food pipe that is not blocking food passage.
- Your cancer is at stage III, meaning it has grown into the stomach wall but has not spread to distant organs.
- You are generally able to perform daily activities and are not bedridden more than half the day.
- Your heart, liver, kidneys, and blood counts are good enough to handle chemotherapy and surgery.
- You have not had chemotherapy or radiation therapy for this cancer before.
- You do not have any other active cancer or serious uncontrolled medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This study compares two approaches for elderly patients with stage III stomach cancer: getting chemotherapy before surgery versus having surgery right away. The goal is to see if starting with chemo improves outcomes and helps patients tolerate treatment better.
This trial tests a combination of chemotherapy drugs given before surgery to shrink advanced stomach cancer tumors and improve outcomes. It may help patients with stage T3/4 or node-positive stomach cancer who have not had prior treatment for their cancer.
This study tests combining an immunotherapy drug (PD-1 inhibitor) and a medication to boost your immune system (thymalfasin) with standard chemotherapy and radiation before surgery for stage III cancer where the stomach meets the esophagus. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests giving chemotherapy through a vein and directly into the belly before surgery for advanced stomach cancer. The goal is to shrink the cancer and see if this approach improves outcomes.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.